Cytek Biosciences Correlations

CTKB Stock  USD 6.50  0.09  1.40%   
The current 90-days correlation between Cytek Biosciences and Orthopediatrics Corp is 0.33 (i.e., Weak diversification). The correlation of Cytek Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cytek Biosciences Correlation With Market

Poor diversification

The correlation between Cytek Biosciences and DJI is 0.65 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytek Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.

Moving together with Cytek Stock

  0.78LH LaboratoryPairCorr
  0.69VREX Varex Imaging CorpPairCorr
  0.79CAH Cardinal HealthPairCorr
  0.67UNH UnitedHealth Group Fiscal Year End 10th of January 2025 PairCorr
  0.72LNSR LENSAR IncPairCorr
  0.77MMSI Merit Medical SystemsPairCorr
  0.69RDNT RadNet IncPairCorr
  0.83ATEC Alphatec Holdings Buyout TrendPairCorr

Moving against Cytek Stock

  0.73TFX Teleflex IncorporatedPairCorr
  0.61GCTK GlucoTrackPairCorr
  0.57ZJYL JIN MEDICAL INTERNATIONALPairCorr
  0.49FEMY FemasysPairCorr
  0.48AHG Akso Health GroupPairCorr
  0.45XTNT Xtant Medical HoldingsPairCorr
  0.43CNC Centene Corp Sell-off TrendPairCorr
  0.38ELV Elevance Health Fiscal Year End 22nd of January 2025 PairCorr
  0.35MASS 908 DevicesPairCorr
  0.62ACET Adicet Bio Buyout TrendPairCorr
  0.44VALN Valneva SE ADRPairCorr
  0.43TNDM Tandem Diabetes CarePairCorr
  0.42NEUE NeueHealth Symbol ChangePairCorr
  0.37MXCT MaxCytePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RXSTKIDS
OFIXTMCI
NPCETMCI
NPCEOFIX
INGNKIDS
SRDXINGN
  
High negative correlations   
RXSTELMD
ELMDKIDS
INGNELMD
TMCIRXST
LUNGELMD
NPCEAXGN

Risk-Adjusted Indicators

There is a big difference between Cytek Stock performing well and Cytek Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cytek Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KIDS  2.45 (0.41) 0.00 (0.23) 0.00 
 4.85 
 16.62 
ELMD  2.50  0.99  0.36  1.07  1.92 
 6.65 
 13.47 
LUNG  3.16 (0.41) 0.00 (0.10) 0.00 
 8.44 
 20.44 
RXST  1.73 (0.42) 0.00 (0.23) 0.00 
 2.19 
 12.89 
AXGN  2.20  0.01  0.01  0.13  3.70 
 4.73 
 21.60 
TMCI  3.14  0.00  0.15  0.12  2.62 
 6.08 
 38.73 
OFIX  1.84  0.02  0.03  0.14  2.07 
 3.90 
 12.11 
NPCE  3.46  0.18  0.10  0.20  3.15 
 9.73 
 35.38 
INGN  1.95 (0.54) 0.00 (0.32) 0.00 
 3.57 
 22.50 
SRDX  0.48 (0.05)(0.21)(0.02) 0.59 
 1.26 
 3.22 

Cytek Biosciences Corporate Management

Todd GarlandChief OfficerProfile
Ming YanCTO DirectorProfile
Melik UlusuSenior ChainProfile
Mark EdingerVP AffairsProfile
Allen PoirsonSenior DevelopmentProfile
Connie WedelChief OfficerProfile